
Johnson & Johnson statistics
$285.75+0.79%Close 13 Nov 2026 · Market value $686.1B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
Johnson & Johnson is valued at $686.1B on its latest close. Its price is 42.6 times its earnings.
| Market value | $686.1B |
|---|
| Enterprise value | $715.3B |
|---|
| Price / earnings | 42.63 |
|---|
| Price / sales | 6.91 |
|---|
| Price / book | 8.42 |
|---|
| EV / EBITDA | 21.79 |
|---|
| EV / sales | 7.20 |
|---|
| Price / free cash flow | 33.32 |
|---|
| Price / free cash flow, own 5-year average | 23.59 |
|---|
| EV / EBIT | 28.84 |
|---|
| EV / free cash flow | 34.65 |
|---|
| Free cash flow yield | 3.0% |
|---|
| Dividend yield | 1.9% |
|---|
Share price
| Latest close | $285.75 |
|---|
| Day's change | +0.8% |
|---|
| 52-week high | $288.11 |
|---|
| 52-week low | $193.45 |
|---|
| From 52-week high | −0.8% |
|---|
| Return · 1 month | +11.8% |
|---|
| Return · 3 months | +6.9% |
|---|
| Return · year to date | +38.1% |
|---|
| Return · 1 year | +47.0% |
|---|
| Beta · 1 year against the S&P 500 | −0.08 |
|---|
| 50-day average | $266.86 |
|---|
| 200-day average | $249.79 |
|---|
| RSI 14 | 65.6 |
|---|
| Average volume · 20 sessions | 7.5M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 67.9% |
|---|
| Operating margin | 26.8% |
|---|
| Net margin | 28.5% |
|---|
| Free cash flow margin | 20.9% |
|---|
| Return on equity | 35.0% |
|---|
| Return on assets | 11.0% |
|---|
| Return on invested capital | 14.5% |
|---|
| Return on invested capital, 5-year average | 13.9% |
|---|
| Return on capital employed | 18.4% |
|---|
| Stock-based compensation / revenue | 1.4% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $19.71B |
|---|
| Total debt | $51.33B |
|---|
| Net debt | $31.23B |
|---|
| Current ratio | 1.03 |
|---|
| Quick ratio | 0.65 |
|---|
| Debt / equity | 0.63 |
|---|
| Net debt / EBITDA | 0.95 |
|---|
| Interest coverage | 26.04 |
|---|
Growth
| Revenue, latest quarter on a year | +5.9% |
|---|
| Revenue, twelve months on a year | +7.8% |
|---|
| EPS, latest quarter on a year | −95.8% |
|---|
| EPS, twelve months on a year | −36.4% |
|---|
| Revenue, 5-year compound | +2.7% |
|---|
| Revenue, 10-year compound | +3.0% |
|---|
| Net income, 5-year compound | +12.8% |
|---|
| Free cash flow, 5-year compound | −0.5% |
|---|
| EPS, 5-year compound | +15.0% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 2.4B |
|---|
| Shares outstanding, 5-year compound | −1.9% |
|---|
| Net share repurchases | $5.95B |
|---|
| Dividends per share | $5.14 |
|---|
| Dividend payout | 46.2% |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $5.78B |
|---|
| Effective tax rate | 17.7% |
|---|
JNJ in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.